Literature DB >> 22046089

Does N ratio affect survival in D1 and D2 lymph node dissection for gastric cancer?

Ibrahim Sakcak1, Barış Doğu Yıldız, Fatih Mehmet Avşar, Saadet Akturan, Kemal Kilic, Erdal Cosgun, Enver O Hamamci.   

Abstract

AIM: To identify whether there could have been changes in survival if lymph node ratio (N ratio) had been used.
METHODS: We assessed 334 gastric adenocarcinoma cases retrospectively between 2001 and 2009. Two hundred and sixteen patients out of 334 were included in the study. Patients were grouped according to disection1 (D1) or dissection 2 (D2) dissection. We compared the estimated survival and actual survival determined by Pathologic nodes (pN) class and N ratio, and SPSS 15.0 software was used for statistical analysis.
RESULTS: Ninety-six (44.4%) patients underwent D1 dissection and 120 (55.6%) had D2 dissection. When groups were evaluated, 23 (24.0%) patients in D1 and 21 (17.5%) in D2 had stage migration (P = 0.001). When both D1 and D2 groups were evaluated for number of pathological lymph nodes, despite the fact that there was no difference in N ratio between D1 and D2 groups, a statistically significant difference was found between them with regard to pN1 and pN2 groups (P = 0.047, P = 0.044 respectively). In D1, pN0 had the longest survival while pN3 had the shortest. In D2, pN0 had the longest survival whereas pN3 had the shortest survival.
CONCLUSION: N ratio is an accurate staging system for defining prognosis and treatment plan, thus decreasing methodological errors in gastric cancer staging.

Entities:  

Keywords:  Gastric cancer; Lymph node dissection; Node ratio; Tumor nodule metastasis

Mesh:

Year:  2011        PMID: 22046089      PMCID: PMC3199559          DOI: 10.3748/wjg.v17.i35.4007

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  25 in total

1.  Lymph node staging in gastric cancer: is location more important than Number? An analysis of 1,038 patients.

Authors:  M S Karpeh; L Leon; D Klimstra; M F Brennan
Journal:  Ann Surg       Date:  2000-09       Impact factor: 12.969

Review 2.  TNM staging for malignancies of the digestive tract: 2003 changes and beyond.

Authors:  Frederick L Greene
Journal:  Semin Surg Oncol       Date:  2003

Review 3.  TNM and Japanese staging systems for gastric cancer: how do they coexist?

Authors:  Mazin E Sayegh; Takeshi Sano; Simon Dexter; Hitoshi Katai; Takeo Fukagawa; Mitsuru Sasako
Journal:  Gastric Cancer       Date:  2004       Impact factor: 7.370

4.  Prognostic impact of metastatic lymph node ratio on gastric cancer after curative distal gastrectomy.

Authors:  Chang-Ming Huang; Jian-Xian Lin; Chao-Hui Zheng; Ping Li; Jian-Wei Xie; Bi-Juan Lin; Jia-Bin Wang
Journal:  World J Gastroenterol       Date:  2010-04-28       Impact factor: 5.742

5.  The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classification.

Authors:  T Kajitani
Journal:  Jpn J Surg       Date:  1981-03

6.  Outcome of ratio of lymph node metastasis in gastric carcinoma.

Authors:  Etsuro Bando; Yutaka Yonemura; Keizo Taniguchi; Sachio Fushida; Takashi Fujimura; Koichi Miwa
Journal:  Ann Surg Oncol       Date:  2002-10       Impact factor: 5.344

7.  Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European monoinstitutional experience.

Authors:  Donato Nitti; Alberto Marchet; Matteo Olivieri; Alessandro Ambrosi; Roberto Mencarelli; Claudio Belluco; Mario Lise
Journal:  Ann Surg Oncol       Date:  2003-11       Impact factor: 5.344

8.  How many nodes must be examined to accurately stage gastric carcinomas? Results from a population based study.

Authors:  Anne-Marie Bouvier; Olivier Haas; Françoise Piard; Philippe Roignot; Claire Bonithon-Kopp; Jean Faivre
Journal:  Cancer       Date:  2002-06-01       Impact factor: 6.860

9.  Appraisal of compliance with the UICC/AJCC staging system in the staging of gastric cancer. Union Internacional Contra la Cancrum/American Joint Committee on Cancer.

Authors:  P J Mullaney; M S Wadley; C Hyde; J Wyatt; G Lawrence; M T Hallissey; J W L Fielding
Journal:  Br J Surg       Date:  2002-11       Impact factor: 6.939

10.  The new TNM classification of lymph node metastasis minimises stage migration problems in gastric cancer patients.

Authors:  G de Manzoni; G Verlato; F Roviello; P Morgagni; A Di Leo; L Saragoni; D Marrelli; H Kurihara; F Pasini
Journal:  Br J Cancer       Date:  2002-07-15       Impact factor: 7.640

View more
  5 in total

Review 1.  Do all the European surgeons perform the same D2? The need of D2 audit in Europe.

Authors:  Maria Bencivenga; Giuseppe Verlato; Valentina Mengardo; Jacopo Weindelmayer; William H Allum
Journal:  Updates Surg       Date:  2018-06-04

2.  A remark on: do all the European surgeons perform the same D2? The need for D2 audit in Europe.

Authors:  Dezső Tóth
Journal:  Updates Surg       Date:  2018-11-20

3.  Prognostic Value of Lymph Node Ratio in Comparison to Lymph Node Metastases in Stage III Colon Cancer.

Authors:  Ali Zare Mirzaei; Fatemeh Abdorrazaghi; Maryam Lotfi; Behrang Kazemi Nejad; Nasrin Shayanfar
Journal:  Iran J Pathol       Date:  2015

4.  Correlation between efficacy of PSK postoperative adjuvant immunochemotherapy for gastric cancer and expression of MHC class I.

Authors:  Gentaro Ito; Hiroaki Tanaka; Masaichi Ohira; Mami Yoshii; Kazuya Muguruma; Naoshi Kubo; Masakazu Yashiro; Nobuya Yamada; Kiyoshi Maeda; Tetsuji Sawada; Kosei Hirakawa
Journal:  Exp Ther Med       Date:  2012-04-02       Impact factor: 2.447

5.  Prognostic significance of metastatic lymph node ratio: the lymph node ratio could be a prognostic indicator for patients with gastric cancer.

Authors:  Yi Hou; Xudong Wang; Jing Chen
Journal:  World J Surg Oncol       Date:  2018-10-04       Impact factor: 2.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.